Vanta Bioscience P/B Ratio

Vanta Bioscience (VANTABIO) P/B ratio is 0.75 (Low), book value per share ₹6.67 vs Healthcare average P/B of -0.18 — Low - Trading below book value, may indicate undervaluation. For live price, earnings yield and the full fundamental profile, see VANTABIO stock price BSE.

Current P/B Ratio
0.75
Low Valuation
Low - Trading below book value, may indicate undervaluation

Current Valuation Metrics

P/B Ratio 0.75
Current Price
Book Value/Share ₹6.67
Exchange None

Book Value Breakdown (2025)

Balance Sheet Components
Total Equity ₹4 Cr
Share Capital ₹6 Cr
Reserves & Surplus ₹4 Cr
Outstanding Shares 6,000,000
Book Value per Share ₹6.67

Valuation Signal

Signal Undervalued

Sector Context

Sector Average -0.18
Sector Median 0.67
Sector Rank #11 of 50
Sector Percentile 22.0%

VANTABIO P/B Ratio — Valuation Insights & Book Value Analysis

Vanta Bioscience price-to-book ratio interpretation, valuation status and historical context — current P/B 0.75 (Low). Check Vanta Bioscience networth to track the company's total market size over time.

  • Stock appears undervalued with PB of 0.75, trading below book value
  • Trading below book value - potential value opportunity or financial distress signal
  • Trading at premium to sector average PB of -0.18

VANTABIO vs Healthcare Peers — P/B Ratio Comparison

Vanta Bioscience P/B 0.75 vs Healthcare average -0.18, median 0.67 — range -13.75–1.1.

Sector Average
-0.18
Sector Median
0.67
Lowest P/B
-13.75
Highest P/B
1.1
Companies
50
Company Symbol P/B Ratio Market Cap (₹ Cr) Valuation
Sun Pharma Advanced Rese… SPARC -13.75 ₹4,814 Low
Span Divergent SDL -6.32 ₹19 Low
Oxygenta Pharmaceutical OXYGENTAPH -5.54 ₹203 Low
Satiate Agri SATAGRI -3.39 ₹8 Low
Adline Chem Lab ADLINE -3.03 ₹5 Low
Bharat Immunologicals BIBCL -2.47 ₹95 Low
Parmax Pharma PARMAX -2.15 ₹12 Low
Krebs Biochemicals & Ind… KREBSBIO -0.96 ₹154 Low
Cresanto Global CRESANTO -0.7 ₹2 Low
Triochem Products TRIPR 0.04 ₹0 Low